Investigating a chimeric anti-mouse PDGFRα antibody as a radiosensitizer in primary mouse sarcomas

BACKGROUND: Olaratumab (LY3012207/IMC-3G3/Lartruvo™) is a fully human monoclonal antibody specific for platelet-derived growth factor receptor alpha (PDGFRα). Phase Ib/II trial results of olaratumab plus doxorubicin in adult patients with advanced soft tissue sarcoma (STS) supported accelerated FDA...

詳細記述

保存先:
書誌詳細
出版年:EBioMedicine
主要な著者: Song, Erin J., Ashcraft, Kathleen A., Lowery, Caitlin D., Mowery, Yvonne M., Luo, Lixia, Ma, Yan, Campos, Lorraine Da Silva, Cardona, Diana M., Stancato, Louis, Kirsch, David G.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2019
主題:
Research paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6413473/
https://ncbi.nlm.nih.gov/pubmed/30711517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.01.046
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料